Matches in Nanopublications for { ?s ?p "[The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP174890.RA4OMxaKp21yrbX2WzVJ3d1ZZgR0LxqektdeTY6qxUWX4130_assertion description "[The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174890.RA4OMxaKp21yrbX2WzVJ3d1ZZgR0LxqektdeTY6qxUWX4130_provenance.
- NP285039.RApRm9zQXgIl_C3rLz3lOKbEJQMV3vS6j3v4P8gM2PKiE130_assertion description "[The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285039.RApRm9zQXgIl_C3rLz3lOKbEJQMV3vS6j3v4P8gM2PKiE130_provenance.
- NP865167.RAc-ZmSsgct5FyRqFhlYneLTxX8jz5LXYMr6SHeFOMbXc130_assertion description "[The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865167.RAc-ZmSsgct5FyRqFhlYneLTxX8jz5LXYMr6SHeFOMbXc130_provenance.
- NP656718.RA_JRPLDwepRWTL99vBDPRV0k-F0torFqUlEmRzfFv-oM130_assertion description "[The rate of COX-2 high-expression was 53.6% (15/28) and 42.9% (6/14) in HNPCC adenoma and carcinoma; 62.5% (20/32) and 91.7% (22/24) in sporadic adenoma and carcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656718.RA_JRPLDwepRWTL99vBDPRV0k-F0torFqUlEmRzfFv-oM130_provenance.